Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO ...

Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.

Independent pharmacies across Kansas will close on Wednesday, Feb.5, for a day of advocacy to raise awareness of what they ...

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

Cigna Group closed 20.66% short of its 52-week high of $370.83, which the company reached on September 16th.

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...

Stephen Baxter, an analyst from Wells Fargo, maintained the Hold rating on Cigna (CI – Research Report). The associated price target remains ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...